Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery
NCT01007500 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 123
Last updated 2016-12-30
Summary
The purpose of this study is to study the effect of dexamethasone combined with ondansetron on postoperative nausea and vomiting in patients with patient-controlled analgesia after video-assisted thoracoscopic surgery.
Conditions
Interventions
- DRUG
-
Experimental: Dexamethasone 8 mg IV after induction of anesthesia, Ondansetron 4 mg IV at the end of surgery and 12 mg mix to intravenous patient controlled analgesia device.
- DRUG
-
Ondansetron
Active comparator: Ondansetron 4 mg IV at the end of surgery and 12 mg mix to intravenous patient controlled analgesia device.
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2010-07-31
- Completion
- 2010-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery
NCT06981754 ·Status: RECRUITING ·Phase: NA
-
The Effect of Prophylactic Antiemetic Dexamethasone on Plasma Cortisol Levels
NCT01524731 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Palmitate for PONV After Open Surgery
NCT06997419 ·Status: RECRUITING ·Phase: NA
-
Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients
NCT04538820 ·Status: UNKNOWN ·Phase: PHASE4
-
Dexamethasone Palmitate for PONV After Craniotomy
NCT06988124 ·Status: RECRUITING ·Phase: NA
-
Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients
NCT01028547 ·Status: COMPLETED ·Phase: NA
-
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
NCT01370408 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy
NCT03177317 ·Status: COMPLETED ·Phase: NA
-
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
NCT00104403 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery
NCT05408676 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
NCT00437229 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer
NCT01116713 ·Status: COMPLETED ·Phase: PHASE3
-
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
NCT00016380 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
NCT00343863 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
NCT00152867 ·Status: COMPLETED ·Phase: PHASE3
-
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
NCT00553059 ·Status: COMPLETED ·Phase: PHASE3
-
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
NCT03125941 ·Status: COMPLETED ·Phase: PHASE4
-
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
NCT01093690 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation
NCT01974024 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin
NCT01012336 ·Status: COMPLETED ·Phase: PHASE2
-
Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea
NCT00781768 ·Status: COMPLETED ·Phase: PHASE4
-
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin
NCT04201769 ·Status: UNKNOWN ·Phase: PHASE3
-
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
NCT00687011 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
NCT00314743 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Anti-emetic Prophylaxis With or Without Dexamethasone
NCT05242874 ·Status: COMPLETED ·Phase: PHASE3